AVE 20.0% 0.3¢ avecho biotechnology limited

re: Ann: Neura Therapeutik Appointed as US St... Thanks KC. Even...

  1. 379 Posts.
    re: Ann: Neura Therapeutik Appointed as US St... Thanks KC. Even a silver medal in swimming - good gracious!

    I'm sure you're right that if POH can start to generate significant cash from one or more applications, then it will affect the picture and impact sentiment. Two points, however

    - with the vast number of shares in issue, POH needs a big jump in revenues to make much difference to the sp. OXY the (only?) real candidate there.

    - however much Management's programmes are 'on track', until there is actually a 'result' (some months away), biotechs being generically seen as prone to nasty shocks I imagine the sp will hang around the mid teens. If all goes as hoped, then zoom!! - but not yet.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $580 200K

Buyers (Bids)

No. Vol. Price($)
34 29443702 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 52585197 27
View Market Depth
Last trade - 13.20pm 18/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.